RegIIIγ promotes the proliferation, and inhibits inflammation response of macrophages by Akt, STAT3 and NF-κB pathways

被引:1
|
作者
Wang, Gaiping [1 ,2 ,3 ,4 ,5 ]
Qiu, Xianglei [1 ,5 ]
Sun, Meiqing [1 ,5 ]
Li, Yingle [1 ,5 ]
Chen, Anqi [1 ,5 ]
Tong, Jiahui [1 ,5 ]
Cheng, Zhipeng [1 ,5 ]
Zhao, Weiming [6 ]
Chang, Cuifang [1 ,2 ,3 ,4 ,5 ]
Yu, Guoying [1 ,2 ,3 ,4 ,5 ]
机构
[1] Henan Normal Univ, State Key Lab Cell Differentiat & Regulat, Xinxiang 453007, Henan, Peoples R China
[2] Henan Normal Univ, Henan Ctr Outstanding Overseas Scientists Organ Fi, Xinxiang 453007, Henan, Peoples R China
[3] Henan Normal Univ, Henan Int Joint Lab Pulm Fibrosis, Xinxiang 453007, Henan, Peoples R China
[4] Henan Normal Univ, Inst Biomed Sci, Xinxiang 453007, Henan, Peoples R China
[5] Henan Normal Univ, Coll Life Sci, Xinxiang 453007, Henan, Peoples R China
[6] Henan Acad Sci, Inst Biomed Sci, Zhengzhou 450046, Henan, Peoples R China
基金
国家重点研发计划;
关键词
Regenerating islet-derived 3 gamma (RegIII gamma); RAW264.7; cells; Inflammation; Cell proliferation; Liver regeneration; LIVER-REGENERATION; KUPFFER CELLS; GENE-EXPRESSION; ALPHA PRODUCTION; MICROBIOTA;
D O I
10.1016/j.intimp.2024.113442
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
As an inflammatory regulator, intestinal regenerating islet-derived 3 gamma (RegIII gamma) contributes to alleviating liver injury in liver diseases and colitis. However, it is unclear whether hepatic RegIII gamma exerts a vital impact on liver regeneration (LR). In this study, the expression profile and localization of RegIII gamma in LR were demonstrated by microarray analysis, qRT-PCR and immunofluorescence staining. Then, RAW264.7 cells with RegIII gamma deficiency and overexpression were obtained by the CRISPR/Cas9 system and lentivirus infection, respectively. MTT, flow cytometry, EdU, transwell, neutral red phagocytosis, and NO assays were performed to detect the functions of RegIII gamma in RAW264.7 cell proliferation and inflammation. Finally, the regulatory mechanism of RegIII gamma was explored by co-immunoprecipitation and Western blot assays. According to our findings, RegIII gamma showed significant expression changes in Kupffer cells during LR, and RegIII gamma overexpression stimulated the viability, proliferation, phagocytosis and migration of RAW264.7 cells, whereas RegIII gamma deficiency reversed these effects. Similarly, RegIII gamma overexpression facilitated the expression of HO-1 and IL-10, while RegIII gamma deficiency promoted NO production and p-Akt, p-STAT3, p-p65 and TNF-alpha expression. In conclusion, RegIII gamma may facilitate LR by promoting the proliferation of macrophages and inhibiting their inflammatory response through Akt, STAT3 and NF-kappa B pathways in the priming stage of LR.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] NCAPG2 overexpression promotes hepatocellular carcinoma proliferation and metastasis through activating the STAT3 and NF-κB/miR-188-3p pathways
    Meng, Fanzheng
    Zhang, Shugeng
    Song, Ruipeng
    Liu, Yao
    Wang, Jiabei
    Liang, Yingjian
    Wang, Jizhou
    Han, Jihua
    Song, Xuan
    Lu, Zhaoyang
    Yang, Guangchao
    Pan, Shangha
    Li, Xianying
    Liu, Yufeng
    Zhou, Fang
    Wang, Yan
    Cui, Yifeng
    Zhang, Bo
    Ma, Kun
    Zhang, Congyi
    Sun, Yufei
    Xin, Mengyang
    Liu, Lianxin
    EBIOMEDICINE, 2019, 44 : 237 - 249
  • [22] Sphingosine kinase 1 promotes growth of glioblastoma by increasing inflammation mediated by the NF-κB/IL-6/STAT3 and JNK/PTX3 pathways
    Wan Li
    Hongqing Cai
    Liwen Ren
    Yihui Yang
    Hong Yang
    Jinyi Liu
    Sha Li
    Yizhi Zhang
    Xiangjin Zheng
    Wei Tan
    Guanhua Du
    Jinhua Wang
    Acta Pharmaceutica Sinica B, 2022, 12 (12) : 4390 - 4406
  • [23] Sphingosine kinase 1 promotes growth of glioblastoma by increasing inflammation mediated by the NF-κB/IL-6/STAT3 and JNK/PTX3 pathways
    Li, Wan
    Cai, Hongqing
    Ren, Liwen
    Yang, Yihui
    Yang, Hong
    Liu, Jinyi
    Li, Sha
    Zhang, Yizhi
    Zheng, Xiangjin
    Tan, Wei
    Du, Guanhua
    Wang, Jinhua
    ACTA PHARMACEUTICA SINICA B, 2022, 12 (12) : 4390 - 4406
  • [24] The STAT3/SETDB2 axis dictates NF-κB-mediated inflammation in macrophages during wound repair
    Mangum, Kevin D.
    Dendekker, Aaron
    Li, Qinmengge
    Tsoi, Lam C.
    Joshi, Amrita D.
    Melvin, William J.
    Wolf, Sonya J.
    Moon, Jadie Y.
    Audu, Christopher O.
    Shadiow, James
    Obi, Andrea T.
    Wasikowski, Rachael
    Barrett, Emily C.
    Bauer, Tyler M.
    Boyer, Kylie
    Ahmed, Zara
    Davis, Frank M.
    Gudjonsson, Johann
    Gallagher, Katherine A.
    JCI INSIGHT, 2024, 9 (20)
  • [25] Platycodin D inhibits proliferation, migration and induces chemosensitization through inactivation of the NF-κB and JAK2/STAT3 pathways in multiple myeloma cells
    Wu, Di
    Zhang, Wei
    Chen, Ying
    Ma, Hong
    Wang, Mengchang
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2019, 46 (12) : 1194 - 1200
  • [26] Embelin Reduces Systemic Inflammation and Ameliorates Organ Injuries in Septic Rats Through Downregulating STAT3 and NF-κB Pathways
    Zhou, Xian-Long
    Huang, Lei
    Cao, Jun
    INFLAMMATION, 2015, 38 (04) : 1556 - 1562
  • [27] Embelin Reduces Systemic Inflammation and Ameliorates Organ Injuries in Septic Rats Through Downregulating STAT3 and NF-κB Pathways
    Xian-Long Zhou
    Lei Huang
    Jun Cao
    Inflammation, 2015, 38 : 1556 - 1562
  • [28] Xanthatin inhibits STAT3 and NF-κB signalling by covalently binding to JAK and IKK kinases
    Liu, Man
    Xiao, Cheng-qian
    Sun, Ming-wei
    Tan, Min-jia
    Hu, Li-hong
    Yu, Qiang
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2019, 23 (06) : 4301 - 4312
  • [29] Chalcone inhibits the activation of NF-κB and STAT3 in endothelial cells via endogenous electrophile
    Liu, Yen-Chin
    Hsieh, Chia-Wen
    Wu, Chun-Ching
    Wung, Being-Sun
    LIFE SCIENCES, 2007, 80 (15) : 1420 - 1430
  • [30] Targeting STAT3 and NF-κB Signaling Pathways in Cancer Prevention and Treatment: The Role of Chalcones
    Krajka-Kuzniak, Violetta
    Belka, Marta
    Papierska, Katarzyna
    CANCERS, 2024, 16 (06)